Skip to main content
Top

Current Oncology Reports

Issue 12/2023

Content (11 Articles)

Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients

Sushant Puri, Amina Chaudhry, Asnakech Bayable, Ashwin Ganesh, Ahmad Daher, Vijayakrishna K. Gadi, Stefania Maraka

Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges

Celeste Manfredi, Francesco Ditonno, Antonio Franco, Eugenio Bologna, Leslie Claire Licari, Davide Arcaniolo, Andrea Tubaro, Cosimo De Nunzio, Alessandro Antonelli, Marco De Sio, Edward E. Cherullo, Riccardo Autorino

Open Access Breast Cancer REVIEW

Postmastectomy Functional Impairments

Eden Marco, Gabrielle Trépanier, Eugene Chang, Emma Mauti, Jennifer M. Jones, Toni Zhong

Open Access Correction

Correction to: Postmastectomy Functional Impairments

Eden Marco, Gabrielle Trépanier, Eugene Chang, Emma Mauti, Jennifer M. Jones, Toni Zhong

Sarcoma REVIEW

Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives

Thien Huong N. Huynh, Davis R. Kuruvilla, Matthew D. Nester, Guston Zervoudakis, G. Douglas Letson, David M. Joyce, Odion T. Binitie, Alexander L. Lazarides

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan

Niraj Neupane, Sangharsha Thapa, Abhinav Bhattarai, Kriti Ahuja, Ilana Schlam, Abhenil Mittal, Sara M. Tolaney, Paolo Tarantino

Open Access Radioimmunotherapy Review

Immune Priming with Spatially Fractionated Radiation Therapy

Lauren Lukas, Hualin Zhang, Karen Cheng, Alan Epstein

Shifting Strategies in the Treatment of Pediatric Craniopharyngioma

Segev Gabay, Thomas E. Merchant, Frederick A. Boop, Jonathan Roth, Shlomi Constantini

Lymphoma Review

Integrative Approaches in the Treatment of Patients Affected by Lymphoma

Ilana Levy Yurkovski, Francesca Andreazzoli, Eran Ben-Arye, Samuel Attias, Tamar Tadmor

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine